FDA And CMS Agree To Share Data Routinely In Possible Step Toward Parallel Reviews
This article was originally published in The Pink Sheet Daily
Executive Summary
Agencies have signed memorandum of understanding for data-sharing, though parallel reviews are "not a done deal."